Faculty Opinions recommendation of Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer.

Author(s):  
Jacques Bernier
Sign in / Sign up

Export Citation Format

Share Document